Have a feature idea you'd love to see implemented?
Let us know!
BSX Boston Scientific Corp
Price (delayed)
$88.95
Market cap
$131.1B
P/E Ratio
72.91
Dividend/share
N/A
EPS
$1.22
Enterprise value
$139.48B
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology,
Highlights
The EPS has increased by 49% YoY
Boston Scientific's net income has increased by 46% YoY
BSX's quick ratio is up by 27% year-on-year but it is down by 11% since the previous quarter
Boston Scientific's debt has increased by 22% YoY and by 3% QoQ
The P/E is 21% above the last 4 quarters average of 60.4
Key stats
What are the main financial stats of BSX
Market
Valuations
Earnings
Shares outstanding
1.47B
Market cap
$131.1B
Enterprise value
$139.48B
Price to earnings (P/E)
72.91
Price to book (P/B)
6.33
Price to sales (P/S)
8.23
EV/EBIT
55.9
EV/EBITDA
37.4
EV/Sales
8.77
Revenue
$15.91B
Gross profit
$10.97B
Net income
$1.79B
EBIT
$2.5B
EBITDA
$3.73B
Free cash flow
$2.18B
Per share
Balance sheet
Liquidity
EPS
$1.22
EPS diluted
$1.21
Free cash flow per share
$1.48
Book value per share
$14.06
Revenue per share
$10.8
TBVPS
$11.74
Total assets
$38.08B
Total liabilities
$17.12B
Debt
$10.89B
Equity
$20.71B
Working capital
$2.85B
Debt to equity
0.53
Current ratio
1.48
Quick ratio
0.85
Net debt/EBITDA
2.25
Margins
Efficiency
Dividend
EBITDA margin
23.4%
Gross margin
69%
Net margin
11.3%
Operating margin
15.8%
Return on assets
4.9%
Return on equity
8.9%
Return on invested capital
13%
Return on capital employed
7.8%
Return on sales
15.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BSX stock price
How has the Boston Scientific stock price performed over time
Intraday
0.33%
1 week
-1.29%
1 month
-1.35%
1 year
61.79%
YTD
53.87%
QTD
6.15%
Financial performance
How have Boston Scientific's revenue and profit performed over time
Revenue
$15.91B
Gross profit
$10.97B
Operating income
$2.51B
Net income
$1.79B
Gross margin
69%
Net margin
11.3%
Boston Scientific's net income has increased by 46% YoY
Boston Scientific's net margin has increased by 27% YoY but it has decreased by 6% QoQ
Boston Scientific's operating income has increased by 16% YoY
The revenue has increased by 16% YoY and by 4.5% from the previous quarter
Growth
What is Boston Scientific's growth rate over time
Valuation
What is Boston Scientific stock price valuation
P/E
72.91
P/B
6.33
P/S
8.23
EV/EBIT
55.9
EV/EBITDA
37.4
EV/Sales
8.77
The EPS has increased by 49% YoY
The P/E is 21% above the last 4 quarters average of 60.4
The stock's price to book (P/B) is 58% more than its 5-year quarterly average of 4.0 and 22% more than its last 4 quarters average of 5.2
The equity has grown by 10% YoY
BSX's P/S is 50% above its 5-year quarterly average of 5.5 and 18% above its last 4 quarters average of 7.0
The revenue has increased by 16% YoY and by 4.5% from the previous quarter
Efficiency
How efficient is Boston Scientific business performance
The return on assets has grown by 36% year-on-year but it has declined by 3.9% since the previous quarter
The return on equity has increased by 35% year-on-year but it has declined by 4.3% since the previous quarter
BSX's ROIC is up by 9% YoY
Dividends
What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BSX.
Financial health
How did Boston Scientific financials performed over time
Boston Scientific's total assets is 122% more than its total liabilities
BSX's quick ratio is up by 27% year-on-year but it is down by 11% since the previous quarter
BSX's total liabilities is up by 15% year-on-year and by 3.8% since the previous quarter
Boston Scientific's debt is 47% lower than its equity
Boston Scientific's debt has increased by 22% YoY and by 3% QoQ
Boston Scientific's debt to equity has increased by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.